Standard BioTools Operating Income 2012-2025 | LAB
Standard BioTools operating income from 2012 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Standard BioTools Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $-175 |
| 2023 | $-77 |
| 2022 | $-116 |
| 2021 | $-67 |
| 2020 | $-51 |
| 2019 | $-52 |
| 2018 | $-48 |
| 2017 | $-58 |
| 2016 | $-73 |
| 2015 | $-50 |
| 2014 | $-52 |
| 2013 | $-19 |
| 2012 | $-18 |
| 2011 | $-19 |
|
Standard BioTools Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-33 |
| 2025-06-30 | $-26 |
| 2025-03-31 | $-33 |
| 2024-12-31 | $-58 |
| 2024-09-30 | $-27 |
| 2024-06-30 | $-30 |
| 2024-03-31 | $-60 |
| 2023-12-31 | $-21 |
| 2023-09-30 | $-21 |
| 2023-06-30 | $-17 |
| 2023-03-31 | $-17 |
| 2022-12-31 | $-21 |
| 2022-09-30 | $-29 |
| 2022-06-30 | $-39 |
| 2022-03-31 | $-28 |
| 2021-12-31 | $-11 |
| 2021-09-30 | $-20 |
| 2021-06-30 | $-17 |
| 2021-03-31 | $-19 |
| 2020-12-31 | $-17 |
| 2020-09-30 | $-5 |
| 2020-06-30 | $-14 |
| 2020-03-31 | $-15 |
| 2019-12-31 | $-9 |
| 2019-09-30 | $-14 |
| 2019-06-30 | $-15 |
| 2019-03-31 | $-14 |
| 2018-12-31 | $-11 |
| 2018-09-30 | $-12 |
| 2018-06-30 | $-13 |
| 2018-03-31 | $-13 |
| 2017-12-31 | $-9 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-16 |
| 2017-03-31 | $-18 |
| 2016-12-31 | $-18 |
| 2016-09-30 | $-18 |
| 2016-06-30 | $-18 |
| 2016-03-31 | $-19 |
| 2015-12-31 | $-14 |
| 2015-09-30 | $-8 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-14 |
| 2014-12-31 | $-10 |
| 2014-09-30 | $-13 |
| 2014-06-30 | $-12 |
| 2014-03-31 | $-17 |
| 2013-12-31 | $-5 |
| 2013-09-30 | $-5 |
| 2013-06-30 | $-4 |
| 2013-03-31 | $-5 |
| 2012-12-31 | $-3 |
| 2012-09-30 | $-4 |
| 2012-06-30 | $-4 |
| 2012-03-31 | $-6 |
| 2011-12-31 | $-3 |
| 2011-09-30 | $-4 |
| 2011-06-30 | $-7 |
| 2011-03-31 | $-5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.581B | $0.174B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.335B | 44.34 |
| Tempus AI (TEM) | United States | $12.322B | 0.00 |
| Doximity (DOCS) | United States | $8.258B | 34.00 |
| Hims & Hers Health (HIMS) | United States | $7.362B | 59.89 |
| IRhythm Technologies (IRTC) | United States | $5.445B | 0.00 |
| Hinge Health (HNGE) | United States | $3.816B | 0.00 |
| Privia Health (PRVA) | United States | $2.881B | 180.15 |
| Inspire Medical Systems (INSP) | United States | $2.816B | 46.60 |
| Heartflow (HTFL) | United States | $2.707B | 0.00 |
| 10x Genomics (TXG) | United States | $2.506B | 0.00 |
| Omnicell (OMCL) | United States | $2.297B | 46.96 |
| Azenta (AZTA) | United States | $1.726B | 70.83 |
| Enovis (ENOV) | United States | $1.541B | 8.09 |
| Schrodinger (SDGR) | United States | $1.373B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.364B | 0.00 |
| Butterfly Network (BFLY) | United States | $1.079B | 0.00 |
| Phreesia (PHR) | United States | $1.033B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.870B | 0.00 |
| Talkspace (TALK) | United States | $0.661B | 133.00 |
| Claritev (CTEV) | United States | $0.528B | 0.00 |
| Evolent Health (EVH) | United States | $0.463B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.387B | 0.00 |
| Carlsmed (CARL) | United States | $0.384B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.348B | 0.00 |
| TruBridge (TBRG) | United States | $0.328B | 15.06 |
| Senseonics Holdings (SENS) | United States | $0.291B | 0.00 |
| CapsoVision (CV) | United States | $0.281B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.204B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.174B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.173B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.162B | 0.00 |
| CareCloud (CCLD) | United States | $0.125B | 6.84 |
| Outset Medical (OM) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.092B | 0.00 |
| HeartBeam (BEAT) | United States | $0.088B | 0.00 |
| Pulmonx (LUNG) | United States | $0.082B | 0.00 |
| American Well (AMWL) | United States | $0.081B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.067B | 0.00 |
| Precipio (PRPO) | United States | $0.046B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.043B | 0.00 |
| 111 (YI) | China | $0.032B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.022B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.021B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.014B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |